List view / Grid view
Scientists have shown that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by MS...
Scientists have identified identified key regulators that are essential for controlling the inflammatory response in Crohn’s disease and multiple sclerosis.
CXCR7 receptor identified as a potential therapeutic target for controlling multiple sclerosis, Parkinson's and AIDS...
MRIs can reveal changes in the brain associated with MS before the clinical symptoms of the disease appear in children...
Scientists have uncovered two closely related cytokines molecules involved in cell communication that explain why some people develop progressive MS...
The ubiquitous human herpes virus 6 (HHV-6) may play a critical role in impeding the brain's ability to repair itself in diseases like multiple sclerosis.
Medically active substances are usually distributed via the blood – either directly or indirectly. In many diseases, however, it is vital to transport the active substance as efficiently as possible to the required target site. This is the case for diseases of the central nervous system, so the treatment of…
In this project, universities and companies across 11 European countries and the US will unite efforts to tailor the development and application of therapies to the individual MS patient.
9 November 2016 | By Dr Hervé Perron, co-founder and Chief Scientific Officer of GeNeuro
GeNeuro's co-founder and CSO Dr Hervé Perron discusses how a HERV protein could be a target for a novel approach in treating multiple sclerosis...
16 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Inhibition of the protein kinase CK2 results in a blockade of exactly those signal pathways required by TH17 cells in order to evolve...
4 August 2016 | By Niamh Marriott, Digital Content Producer
Chronos Therapeutics, a biotech company researching ageing diseases, brain and nervous system disorders, have announced the appointment of Dr Fraser Murray and Dr Timothy Schulz-Utermoehl, as Vice Presidents of Pre-Clinical Development...
9 May 2016 | By Victoria White, Digital Content Producer
New research suggests that gut microbes may remotely influence the activity of cells in the brain that are involved in inflammation and neurodegeneration...
19 February 2016 | By Victoria White
The discovery could change the way researchers understand and treat autoimmune diseases such as type 1 diabetes and multiple sclerosis...
4 February 2016 | By Victoria White
Compounds that produce elevated levels of TTP in humans may offer an effective treatment for inflammatory diseases, such as rheumatoid arthritis and multiple sclerosis...
21 January 2016 | By Hans Fliri PhD, Chairman, Cypralis
Here, Dr Hans Fliri, Chairman and CEO of Selcia and Chairman of Cypralis, presents a strong case for targeting mitochondrial cyclophilin D to prevent progression of chronic neurodegenerative diseases...
